Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,116,101
-$381,289 QoQ
Shares Held
710,297
-22.1% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. ALKS ranks #9 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
99,106 | $58,767,875 | |
| 2 | VTRS |
Viatris Inc
|
3,882,541 | $52,453,128 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,602,543 | $48,199,096 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
959,257 | $46,188,223 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,788,811 | $45,175,103 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
1,982,724 | $44,809,561 | |
| 7 | LQDA |
Liquidia Corp
|
873,065 | $32,949,472 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
622,450 | $32,174,439 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,116,101 | 710,297 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,497,390 | 911,272 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,862,470 | 528,749 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $23,462,945 | 820,096 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,469,242 | 468,481 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,988,459 | 555,927 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,553,566 | 555,683 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,787,697 | 323,141 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,253,635 | 341,841 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,710,130 | 638,433 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $27,018,277 | 964,594 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,334,674 | 681,619 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,524,252 | 444,280 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,929,479 | 571,354 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,543,242 | 248,242 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,188,109 | 274,861 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,574,443 | 59,842 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,393,766 | 188,898 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,377,578 | 77,094 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,328,687 | 176,537 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,231,217 | 65,911 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,121,564 | 407,096 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $11,082,896 | 570,989 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $12,581,334 | 872,492 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||